Cormorant Asset Management, LP

Holdings History for ACCELERON PHARMA INC - COMMON STOCK (XLRN)

Symbol: XLRN
Investment type: Equity / COMMON STOCK

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
30 Sep 2021		-0.86%	$0	0	-175,000	-100%	$179.00	Q3 2021
30 Jun 2021	0.86%	-0.49%	$21,961,000	175,000	-100,000	-36%	$125.49	Q2 2021
31 Mar 2021	1.1%	-0.59%	$37,293,000	275,000	-150,000	-35%	$135.61	Q1 2021
31 Dec 2020	1.6%	-0.28%	$54,374,000	425,000	-75,000	-15%	$127.94	Q4 2020
30 Sep 2020	2.5%	-0.5%	$56,265,000	500,000	-100,000	-17%	$112.53	Q3 2020
30 Jun 2020	2.5%	-0.94%	$57,162,000	600,000	-225,000	-27%	$95.27	Q2 2020
31 Mar 2020	4.2%	+4.2%	$74,143,000	825,000	+825,000	NEW	$89.87	Q1 2020
31 Dec 2019		-0.07%	$0	0	-25,000	-100%	$179.00	Q4 2019
30 Sep 2019	0.07%	-0.04%	$988,000	25,000	-15,000	-38%	$39.52	Q3 2019
30 Jun 2019	0.1%	0%	$1,643,000	40,000	0		$41.08	Q2 2019
31 Mar 2019	0.13%	-0.03%	$1,863,000	40,000	-8,695	-18%	$46.58	Q1 2019
31 Dec 2018	0.19%	-0.01%	$2,121,000	48,695	-1,305	-2.6%	$43.56	Q4 2018
30 Sep 2018	0.21%	-0.09%	$2,862,000	50,000	-21,667	-30%	$57.24	Q3 2018
30 Jun 2018	0.28%	0%	$3,477,000	71,667	0		$48.52	Q2 2018
31 Mar 2018	0.24%	-0.01%	$2,802,000	71,667	-3,333	-4.4%	$39.10	Q1 2018
31 Dec 2017	0.37%	0%	$3,183,000	75,000	0		$42.44	Q4 2017
30 Sep 2017	0.49%	0%	$2,799,000	75,000	0		$37.32	Q3 2017
30 Jun 2017	0.38%	0%	$2,279,000	75,000	0		$30.39	Q2 2017
31 Mar 2017	0.29%	-0.2%	$1,985,000	75,000	-52,451	-41%	$26.47	Q1 2017
31 Dec 2016	0.44%	0%	$3,253,000	127,451	0		$25.52	Q4 2016
30 Sep 2016	0.51%	0%	$4,612,000	127,451	0		$36.19	Q3 2016
30 Jun 2016	0.61%	-0.35%	$4,331,000	127,451	-72,549	-36%	$33.98	Q2 2016
31 Mar 2016	0.8%	0%	$5,278,000	200,000	0		$26.39	Q1 2016
31 Dec 2015	1.2%	0%	$9,752,000	200,000	0		$48.76	Q4 2015
30 Sep 2015	0.8%	0%	$4,980,000	200,000	0		$24.90	Q3 2015
30 Jun 2015	0.84%	+0.13%	$6,328,000	200,000	+30,000	+18%	$31.64	Q2 2015
31 Mar 2015	1%	-0.47%	$6,470,000	170,000	-80,000	-32%	$38.06	Q1 2015
31 Dec 2014	1.5%	-0.9%	$9,740,000	250,000	-150,000	-38%	$38.96	Q4 2014
30 Sep 2014	2.5%	+1.2%	$12,096,000	400,000	+200,000	+100%	$30.24	Q3 2014
30 Jun 2014	1.8%	+1.8%	$6,794,000	200,000	+200,000	NEW	$33.97	Q2 2014

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.